Table 3.

Phenotypic characterization of ACV-resistant isolates

Immune statusTreatment statusNo. of isolates
TK variantsDNA PolUnclas- sified
DeficientAltered
ImmunocompetentUntreated0102
ImmunocompetentACV treateda 1000
ImmunocompromisedACV treated5100
ImmunocompetentUnknown1000
  • ↵a Most patients were receiving episodic treatment.